News about

(MWIV) MWI Veterinary Supply Earnings Beat – Sales Miss

Thu, 16 May 2013 16:22:43 -0400

MWI Veterinary Supply (MWIV) reported second-quarter fiscal 2013 earnings per share (EPS) of $1.19,...

Visit StockBlogHub to view complete post.

Accuray Lags 3Q Earnings Est – Analyst Blog

Wed, 08 May 2013 18:04:01 -0400

Accuray Incorporated???s (ARAY) third-quarter fiscal 2013 adjusted loss of 37 cents per share.

MYGN Earnings Easily Beat, Guidance Up – Analyst Blog

Wed, 08 May 2013 17:25:01 -0400

Myriad Genetics reported earnings per share (EPS) of 46 cents in the third quarter of fiscal 2013, representing a beat of 17.9% over the Zacks Consensus Estimate.

Accuray Lags 3Q Earnings Est – Analyst Blog

Wed, 08 May 2013 17:18:01 -0400

Third-quarter fiscal 2013 adjusted loss of 37 cents per share was wider than the Zacks Consensus Estimate of a loss of 21 cents.

MWI Vet Earnings Beat, Sales Miss – Analyst Blog

Fri, 03 May 2013 13:20:01 -0400

MWI Vet earnings beat the Zacks Consensus Estimate in the second quarter of fiscal 2013.

Merge 1Q13: Loss Widens; Meets Est – Analyst Blog

Thu, 02 May 2013 16:00:01 -0400

Merge suffers net loss, revenues in 1Q13 meet the Zacks Consensus Estimates.

DexCom Loss Narrower than Est. – Analyst Blog

Thu, 02 May 2013 15:10:01 -0400

Dexcom's loss shrinks year over year in the first quarter 2013 on higher revenues.

Luminex Beats 1Q Earnings Est. – Analyst Blog

Wed, 01 May 2013 06:35:01 -0400

Luminex first-quarter adjusted earnings topped the Zacks Consensus Estimate but one-time expenses resulted in net loss.

Varian Beats Earnings and Rev Est – Analyst Blog

Thu, 25 Apr 2013 15:10:01 -0400

Varian beats the Zacks Consensus Estimates for revenues and earnings.

Varian to Work with PSI on IMPT – Analyst Blog

Mon, 22 Apr 2013 15:10:01 -0400

Varian and PSI recently revealed a collaborative effort to pursue further knowledge in advanced management of motion in the field of proton therapy.

Intuitive Surgical Beats on Higher Revs – Analyst Blog

Fri, 19 Apr 2013 15:55:01 -0400

Intuitive Surgical's first quarter 2013 revenues and earnings beat the Zacks Consensus Estimate.

Cepheid Earnings Beat, Retains Outlook – Analyst Blog

Fri, 19 Apr 2013 12:20:01 -0400

Cepheid tops Zacks Consensus Estimate in the first quarter of 2013.

Varian Applies Latest Vitesse – Analyst Blog

Wed, 17 Apr 2013 15:42:01 -0400

Varian Medical Systems recently revealed that a patient with prostate cancer was the first to receive therapy from the most current edition of Varian's Vitesse.

Milestone for Accuray TomoTherapy – Analyst Blog

Fri, 05 Apr 2013 15:20:01 -0400

Accuray announced that Heidelberg University Hospital is the first to use its new TomoEDGE Dynamic Jaws technology combined with VoLO Planning for patient treatment.

Varian Spotlights Calypso – Analyst Blog

Mon, 01 Apr 2013 15:50:01 -0400

Varian Medical Systems revealed that it was raising the profile of the Calypso System as a mechanism for medical practitioners to curtail the risk of heart ailments developed by women after many years following therapy for breast cancer.

Accuray Upgraded to Neutral – Analyst Blog

Fri, 22 Mar 2013 19:33:01 -0400

We upgraded our recommendation for Accuray from 'Underperform' to 'Neutral'.

Accuray Beats Despite Wider Loss – Analyst Blog

Fri, 08 Feb 2013 09:00:01 -0500

Accuray beat both earnings and revenue estimates in the second quarter but profit declined.

Stocks Hitting 52-Week Lows

Thu, 07 Feb 2013 10:23:24 -0500

OraSure Technologies (NASDAQ: OSUR) shares dropped 9.76% to touch a new 52-week low of $6.34. OraSure issued downbeat Q1 forecast.

Accuray (NASDAQ: ARAY) shares touched a new 52-week low of $4.585. Accuray announced proposed offering of $75 million of convertible senior notes due 2018.

Rubicon Technology (NASDAQ:

Accuray Announces Proposed Offering Of $75M Of Convertible Senior Notes

Wed, 06 Feb 2013 16:36:09 -0500

Accuray Incorporated (Nasdaq: ARAY) today announced its intention to commence an offering, subject to market and other conditions, of $75 million aggregate principal amount of convertible senior notes due 2018 (the "notes"), to be offered and sold to qualified institutional buyers pursuant to Rule 144A under the Securities

Varian Products Expand to Algeria – Analyst Blog

Wed, 30 Jan 2013 17:56:01 -0500

Varian will be selling its radiotherapy systems to the Algerian government.

Intuitive Surgical to Outperform – Analyst Blog

Wed, 30 Jan 2013 14:20:01 -0500

We retain Intuitive Surgical at Outperform following its strong fourth quarter 2012 results.

FDA Clears Varian’s Vitesse – Analyst Blog

Tue, 29 Jan 2013 17:08:01 -0500

Varian has won the U.S. FDA 510(k) clearance for its Vitesse software.

Reiterate Varian at Neutral – Analyst Blog

Tue, 29 Jan 2013 14:30:01 -0500

We reiterate Varian Medical Systems at Neutral following its fiscal first quarter 2013 results.

(VAR) Varian Medical Systems Receives FDA Clearance

Tue, 29 Jan 2013 14:11:39 -0500

Oncology and X-Ray products company Varian Medical Systems (VAR) recently revealed that it has...

Visit StockBlogHub to view complete post.

Varian Receives FDA Clearance – Analyst Blog

Mon, 28 Jan 2013 14:20:01 -0500

Varian Medical Systems recently revealed that it received FDA 510(k) clearance for its Edge radiosurgery suite, which is the company's latest offering for radiosurgery.

Varian Beats Estimates, Profit Up – Analyst Blog

Thu, 24 Jan 2013 08:30:01 -0500

Varian beats Zacks Consensus Estimates for the fiscal first quarter and profit increases.

Intuitive Beats Zacks Estimates – Analyst Blog

Wed, 23 Jan 2013 08:30:01 -0500

Intuitive Surgical's fourth quarter and 2012 revenues and earnings beat the Zacks Consensus Estimate.

Intuitive Preview: Set to Beat – Analyst Blog

Mon, 21 Jan 2013 16:00:01 -0500

Intuitive Surgical is a case of likely positive surprise when the company announces results on Jan 22.

Bearish MACD for Accuray Inc. – Tale of the Tape

Fri, 18 Jan 2013 10:49:01 -0500

Bearish MACD for Accuray Inc.

Will the ObamaCare Excise Tax Kill the Medical Device Sector?

Tue, 08 Jan 2013 16:00:31 -0500

There is little doubt that the 2.3 percent excise tax on medical devices, imbedded in the Affordable Care Act, will have an impact on medical device stocks. The question is how big?

A battalion of naysayers has predicted doom and gloom for medical device manufacturers and importers because of the implementation

Accuray’s Outlook Disappoints – Analyst Blog

Mon, 07 Jan 2013 11:10:01 -0500

Accuray announced preliminary results for the second quarter of fiscal 2013 and also provided guidance for fiscal 2013.

UPDATE: Jefferies & Company Reiterates Buy Rating, Lowers PT on Accuray

Fri, 04 Jan 2013 12:35:19 -0500

In a report published Friday, Jefferies & Company reiterated its Buy rating on Accuray (NASDAQ: ARAY), but lowered its price target from $10.00 to $6.50.

Jefferies noted, “Accuray posted preliminary F2Q results well below expectations and drastically reduced its F13 guidance. The reset under new management was expected but

Friday’s biggest gaining and declining stocks

Fri, 04 Jan 2013 08:56:13 -0500

Amicus, Harvest Natural and Finish Line are all on the move, while metals ETFs are the talk of Twitter after Thursday’s Fed minutes prompted a big selloff in gold and silver.

Varian’s TrueBeam in South America – Analyst Blog

Wed, 19 Dec 2012 11:40:01 -0500

Varian Medical Systems recently revealed that the Clinicas Oncologicas Integradas (GRUPO COI) is the first cancer treatment center in South America to order a TrueBeam system for treating tumors.

Varian Wins Clearance in India – Analyst Blog

Fri, 30 Nov 2012 11:30:01 -0500

Varian Medical Systems reveals permission from the Indian Atomic Energy Regulatory Board for usage of its TrueBeam High Intensity Mode for cancer treatment. The company's cancer treatment equipment is on display in Kolkata this week.

Accuray Down to Underperform – Analyst Blog

Wed, 28 Nov 2012 09:30:01 -0500

We are downgrading our recommendation for Accuray to 'Underperform' from 'Neutral'.

Varian’s Clinac Goes to Kenya – Analyst Blog

Mon, 19 Nov 2012 17:38:01 -0500

Varian's Clinac DMX equipment was recently installed at The Nairobi Hospital in Kenya.

Accuray Misses Ests, Loss Widens – Analyst Blog

Fri, 09 Nov 2012 13:53:01 -0500

Accuray missed both earnings and revenue estimates for 1Q13, and profits plunged as well.

Varian Grant for Radiology Board – Analyst Blog

Wed, 07 Nov 2012 16:10:01 -0500

Varian Medical Systems provided a grant of $100,000 to the American Board of Radiology Foundation to set up a nation-wide brachytherapy registry.

Zacks #5 Rank Additions for Wednesday – Tale of the Tape

Wed, 07 Nov 2012 08:14:01 -0500

Here are 5 stocks added to the Zacks #5 Rank ("strong sell") List for Wednesday

(ARAY) FDA Clears Accuray’s CyberKnife M6

Tue, 06 Nov 2012 09:43:44 -0500

Renowned radiosurgery systems maker, Accuray Incorporated (ARAY) recently received the U.S. Food...

Visit StockBlogHub to view complete post.

FDA Clears Accuray’s CyberKnife M6 – Analyst Blog

Mon, 05 Nov 2012 16:55:01 -0500

Accuray received FDA 510(k) approval for its new Cybernife M6 Series, featuring the InCise Multileaf Collimator.

Varian shows its EDGE – Analyst Blog

Mon, 05 Nov 2012 11:50:01 -0500

Varian shows the latest EDGE Radiosurgery Suite, which is a composite system for radiosurgery utilizing tumor monitoring know how and management of motion.

Intuitive Remains Neutral – Analyst Blog

Mon, 29 Oct 2012 12:40:01 -0400

We retain Intuitive Surgical at Neutral based on its third quarter results.

Varian Beats Comfortably; Up Y-Y – Analyst Blog

Fri, 26 Oct 2012 11:50:01 -0400

Varian beats Zacks Consensus Estimates for fourth quarter as well as fiscal 2012.

Intuitive Beats Estimates in 3Q – Analyst Blog

Wed, 17 Oct 2012 12:15:01 -0400

Intuitive's third quarter results beat the Zacks Consensus Estimates.

Varian’s Calypso Gains Popularity – Analyst Blog

Mon, 15 Oct 2012 12:00:01 -0400

Harley Street Clinic, a major healthcare facility in London, U.K., adopts the Calypso system to ensure timely monitoring of tumors during prostate cancer radiotherapy sessions.

Earnings Preview: Intuitive – Analyst Blog

Fri, 12 Oct 2012 17:55:01 -0400

Intuitive Surgical expected to report its third quarter 2012 earnings results on Tuesday, October 16.

(ISRG) Intuitive Surgical Earnings Preview

Fri, 12 Oct 2012 17:15:51 -0400

Intuitive Surgical (ISRG) is slated to report its third quarter results on Tuesday, October 16,...

Visit StockBlogHub to view complete post.

(SNN) MedTech Industry Stock Outlook – October 2012 – Zacks Analyst Interviews

Thu, 04 Oct 2012 18:43:14 -0400

The global medical devices industry is fairly large, intensely competitive and highly innovative. A...

Visit StockBlogHub to view complete post.